Hypermethylation of the SEPT9 Gene Suggests Significantly Poor Prognosis in Cancer Patients: A Systematic Review and Meta-Analysis
Background: Aberrant hypermethylation of the Septin 9 (SEPT9) is an early event in several human cancers, and increasing studies have reported good performance of methylated SEPT9 (mSEPT9) in cancer diagnosis. Recent studies further focused on its value in cancer prognosis, but results are not clear...
Main Authors: | Na Shen, Ting Wang, Delei Li, Yaowu Zhu, Huaping Xie, Yanjun Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2019.00887/full |
Similar Items
-
Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population
by: Kepu Zheng, et al.
Published: (2023-07-01) -
Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer
by: Luyao Zhao, et al.
Published: (2022-10-01) -
Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer
by: Yi Liu, et al.
Published: (2020-04-01) -
ACTN4 Mediates SEPT14 Mutation-Induced Sperm Head Defects
by: Yu-Hua Lin, et al.
Published: (2020-11-01) -
Pediatric M5 acute myeloid leukemia with MLL-SEPT6 fusion and a favorable outcome
by: Alain Chebly, et al.
Published: (2021-01-01)